Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
This report contains market size and forecasts of Interventional Cardiology in global, including the following market information:
Global Interventional Cardiology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interventional Cardiology Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Interventional Cardiology companies in 2021 (%)
The global Interventional Cardiology market was valued at 3248.4 million in 2021 and is projected to reach US$ 3908.9 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiology Catheters Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interventional Cardiology include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE and Co. KG, Bard Peripheral Vascular，Inc, TERUMO CORPORATION, KANEKA and OrbusNeich Medical, BV, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interventional Cardiology manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interventional Cardiology Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interventional Cardiology Market Segment Percentages, by Type, 2021 (%)
Cardiology Catheters
Guidewires
Balloon Catheters
Coronary Stents
Fractional Flow Reserve
Intravascular Ultrasound
Global Interventional Cardiology Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interventional Cardiology Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Interventional Cardiology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interventional Cardiology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interventional Cardiology revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interventional Cardiology revenues share in global market, 2021 (%)
Key companies Interventional Cardiology sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Interventional Cardiology sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE and Co. KG
Bard Peripheral Vascular，Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort